PDHA1 and neoplasm: In addition, the lung cancer patients with the higher p-PDHA1 and PKM2 levels, when determined by Western blotting of tumor samples (Figure 6L,M,O), markedly reduced survival probability (Figure 6N–P and Supplementary Figure S3B).